Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo

References

• Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–1053. doi:10.2337/diacare.27.5.104715111519
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986. doi:10.1056/NEJM1993093032914018366922
   PubMed Web of Science ®Google Scholar
• Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287(19):2570–2581. doi:10.1001/jama.287.19.257012020339
   PubMed Web of Science ®Google Scholar
• Creager MA, Luscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation. 2003;108(12):1527–1532. doi:10.1161/01.CIR.0000091257.27563.3214504252
   PubMed Web of Science ®Google Scholar
• De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol. 2000;130(5):963–974. doi:10.1038/sj.bjp.070339310882379
   PubMed Web of Science ®Google Scholar
• Tesfamariam B, Brown ML, Deykin D, Cohen RA. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest. 1990;85(3):929–932. doi:10.1172/JCI1145212312734
   PubMedGoogle Scholar
• Ceriello A, Novials A, Ortega E, et al. Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes. Diabetes. 2012;61(11):2993–2997. doi:10.2337/db12-022422891214
   PubMed Web of Science ®Google Scholar
• Suzuki LA, Poot M, Gerrity RG, Bornfeldt KE. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels. Diabetes. 2001;50(4):851–860. doi:10.2337/diabetes.50.4.85111289052
   PubMedGoogle Scholar
• Makino A, Nakamura T, Hirano M, et al. High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus. Atherosclerosis. 2010;213(2):573–578. doi:10.1016/j.atherosclerosis.2010.09.00420934703
   PubMedGoogle Scholar
• Marfella R, Di Filippo C, Baldi A, et al. The vascular smooth muscle cells apoptosis in asymptomatic diabetic carotid plaques: role of glycemic control. J Am Coll Cardiol. 2006;47(10):2118–2120. doi:10.1016/j.jacc.2006.02.02516697334
   PubMedGoogle Scholar
• Morice MC, Serruys PW, Barragan P, et al. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial. J Am Coll Cardiol. 2007;50(14):1299–1304. doi:10.1016/j.jacc.2007.06.02917903626
   PubMedGoogle Scholar
• Silber S, Colombo A, Banning AP, et al. Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions. Circulation. 2009;120(15):1498–1504. doi:10.1161/CIRCULATIONAHA.109.84987719786634
   PubMedGoogle Scholar
• Losordo DW, Isner JM, Diaz-Sandoval LJ. Endothelial recovery: the next target in restenosis prevention. Circulation. 2003;107(21):2635–2637. doi:10.1161/01.CIR.0000071083.31270.C312782613
   PubMedGoogle Scholar
• Kipshidze N, Dangas G, Tsapenko M, et al. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol. 2004;44(4):733–739. doi:10.1016/j.jacc.2004.04.04815312851
   PubMed Web of Science ®Google Scholar
• Kalra S, Unnikrishnan AG, Agrawal N, Singh AK. Linagliptin and newer DPP-4 inhibitors: newer uses and newer indications. Recent Pat Endocr Metab Immune Drug Discov. 2011;5(3):197–202.21913883
   PubMedGoogle Scholar
• van Poppel PC, Netea MG, Smits P, Tack CJ. Vildagliptin improves endothelium-dependent vasodilatation in type 2 diabetes. Diabetes Care. 2011;34(9):2072–2077. doi:10.2337/dc10-242121788633
   PubMed Web of Science ®Google Scholar
• Ervinna N, Mita T, Yasunari E, et al. Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice. Endocrinology. 2013;154(3):1260–1270. doi:10.1210/en.2012-185523337530
   PubMed Web of Science ®Google Scholar
• Duan G, Fang H, Huang C, Jiang S, Hou H. Microstructures and mechanical properties of aligned electrospun carbon nanofibers from binary composites of polyacrylonitrile and polyamic acid. J Mater Sci. 2018;53(21):15096–15106. doi:10.1007/s10853-018-2700-y
   Web of Science ®Google Scholar
• Guo M, Bi S, Liu J, et al. C60 (OH) n-loaded nanofibrous membranes protect HaCaT cells from ROS-associated damage. Chin Chem Lett. 2017;28(9):1889–1892. doi:10.1016/j.cclet.2017.07.021
   Web of Science ®Google Scholar
• Jiang S, Han D, Huang C, Duan G, Hou H. Temperature-induced molecular orientation and mechanical properties of single electrospun polyimide nanofiber. Mater Lett. 2018;216:81–83. doi:10.1016/j.matlet.2017.12.146
   Web of Science ®Google Scholar
• Duan G, Greiner A. Air-blowing-assisted coaxial electrospinning toward high productivity of core/sheath and hollow fibers. Macromolecular Materials and Engineering. 2019;304:1800669.
   Web of Science ®Google Scholar
• Gao S, Tang G, Hua D, et al. Stimuli-responsive bio-based polymeric systems and their applications. J Mater Chem B. 2019;7(5):709–729. doi:10.1039/C8TB02491J
   PubMed Web of Science ®Google Scholar
• Lv D, Wang R, Tang G, et al. Eco-friendly electrospun membranes loaded with visible-light response nano-particles for multifunctional usages: high-efficient air filtration, dye scavenger and bactericide. ACS Appl Mater Interfaces. 2019. doi:10.1021/acsami.9b01508
   Web of Science ®Google Scholar
• Bosi E, Camisasca RP, Collober C, Rochotte E, Garber AJ. Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin. Diabetes Care. 2007;30(4):890–895. doi:10.2337/dc06-173217277036
   PubMed Web of Science ®Google Scholar
• Teo WE, Ramakrishna S. A review on electrospinning design and nanofibre assemblies. Nanotechnology. 2006;17(14):R89–R106. doi:10.1088/0957-4484/17/14/R0119661572
   PubMed Web of Science ®Google Scholar
• Boovizhikannan T, Palanirajan VK. RP-HPLC determination of vildagliptin in pure and in tablet formulation. J Pharm Res. 2013;7(1):113–116. doi:10.1016/j.jopr.2013.01.001
   Google Scholar
• Wang J, Wan R, Mo Y, Zhang Q, Sherwood LC, Chien S. Creating a long-term diabetic rabbit model. Exp Diabetes Res. 2010;2010:289614. doi:10.1155/2010/28961421234414
   PubMedGoogle Scholar
• Lee CH, Chang SH, Lin YH, et al. Acceleration of re-endothelialization and inhibition of neointimal formation using hybrid biodegradable nanofibrous rosuvastatin-loaded stents. Biomaterials. 2014;35(15):4417–4427. doi:10.1016/j.biomaterials.2014.02.01724582553
   PubMedGoogle Scholar
• Dolgov V, Zaikina O, Bondarenko M, Repin V. Aortic endothelium of alloxan diabetic rabbits: a quantitative study using scanning electron microscopy. Diabetologia. 1982;22(5):338–343.7047281
   PubMed Web of Science ®Google Scholar
• Lee CH, Lin YH, Chang SH, et al. Local sustained delivery of acetylsalicylic acid via hybrid stent with biodegradable nanofibers reduces adhesion of blood cells and promotes reendothelialization of the denuded artery. Int J Nanomedicine. 2014;9:311–326. doi:10.2147/IJN.S5125824421640
   PubMed Web of Science ®Google Scholar
• Drolet MC, Plante E, Battistini B, Couet J, Arsenault M. Early endothelial dysfunction in cholesterol-fed rabbits: a non-invasive in vivo ultrasound study. Cardiovasc Ultrasound. 2004;2:10. doi:10.1186/1476-7120-2-1015268763
   PubMedGoogle Scholar
• Nakazawa G, Granada JF, Alviar CL, et al. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization. JACC Cardiovasc Interv. 2010;3(1):68–75. doi:10.1016/j.jcin.2009.09.01520129572
   PubMed Web of Science ®Google Scholar
• Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol. 1998;31(1):224–230. doi:10.1016/s0735-1097(97)00450-69426044
   PubMed Web of Science ®Google Scholar
• Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol. 1992;19(2):267–274. doi:10.1016/0735-1097(92)90476-41732351
   PubMed Web of Science ®Google Scholar
• Ko Y-G, Park JH, Lee JB, et al. Growth behavior of endothelial cells according to electrospun poly(D,L-lactic-co-glycolic acid) fiber diameter as a tissue engineering scaffold. Tissue Eng Regen Med. 2016;13(4):343–351. doi:10.1007/s13770-016-0053-730603416
   PubMedGoogle Scholar
• Hassiba AJ, El Zowalaty ME, Nasrallah GK, et al. Review of recent research on biomedical applications of electrospun polymer nanofibers for improved wound healing. Nanomedicine (Lond). 2016;11(6):715–737. doi:10.2217/nnm.15.21126744905
   PubMed Web of Science ®Google Scholar
• Evers H, Birngruber CG, Ramsthaler F, Muller U, Bruck S, Verhoff MA. Differentiation of epithelial cell types by cell diameter. Arch Kriminol. 2011;228(1–2):11–19.21850882
   PubMedGoogle Scholar
• Makadia HK, Siegel SJ. Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3(3):1377–1397. doi:10.3390/polym303137722577513
   PubMed Web of Science ®Google Scholar
• Eniola AO, Hammer DA. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activity. Biomaterials. 2005;26(6):661–670. doi:10.1016/j.biomaterials.2004.03.00315282144
   PubMedGoogle Scholar
• de Prado AP, Perez-Martinez C, Cuellas-Ramon C, et al. Time course of reendothelialization of stents in a normal coronary swine model: characterization and quantification. Vet Pathol. 2011;48(6):1109–1117. doi:10.1177/030098581140044621393629
   PubMedGoogle Scholar
• Shigeta T, Aoyama M, Bando YK, et al. Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions. Circulation. 2012;126(15):1838–1851. doi:10.1161/CIRCULATIONAHA.112.09647923035207
   PubMedGoogle Scholar
• Joner M, Nakazawa G, Finn AV, et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol. 2008;52(5):333–342. doi:10.1016/j.jacc.2008.04.03018652940
   PubMed Web of Science ®Google Scholar
• Otsuka F, Finn AV, Yazdani SK, Nakano M, Kolodgie FD, Virmani R. The importance of the endothelium in atherothrombosis and coronary stenting. Nat Rev Cardiol. 2012;9(8):439–453. doi:10.1038/nrcardio.2012.6422614618
   PubMed Web of Science ®Google Scholar
• Wilensky RL, March KL, Gradus-Pizlo I, Sandusky G, Fineberg N, Hathaway DR. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. Circulation. 1995;92(10):2995–3005. doi:10.1161/01.cir.92.10.29957586270
   PubMedGoogle Scholar
• Nistala R, Habibi J, Aroor A, et al. DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat. Obesity. 2014;22(10):2172–2179. doi:10.1002/oby.2083324995775
   PubMedGoogle Scholar
• Fadini GP, Avogaro A. Cardiovascular effects of DPP-4 inhibition: beyond GLP-1. Vascul Pharmacol. 2011;55(1–3):10–16. doi:10.1016/j.vph.2011.05.00121664294
   PubMed Web of Science ®Google Scholar
• Sundback CA, Shyu JY, Wang Y, et al. Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material. Biomaterials. 2005;26(27):5454–5464. doi:10.1016/j.biomaterials.2005.02.00415860202
   PubMed Web of Science ®Google Scholar
• Akita K, Isoda K, Shimada K, Daida H. Dipeptidyl-peptidase-4 inhibitor, alogliptin, attenuates arterial inflammation and neointimal formation after injury in low–density lipoprotein (LDL) receptor-deficient mice. J Am Heart Assoc. 2015;4(3):e001469. doi:10.1161/JAHA.114.00146925770025
   PubMed Web of Science ®Google Scholar
• Terawaki Y, Nomiyama T, Kawanami T, et al. Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury. Cardiovasc Diabetol. 2014;13:154. doi:10.1186/1475-2840-13-8025407968
   PubMed Web of Science ®Google Scholar
• Koyama A, Komori K, Otsuka R, Kajikuri J, Itoh T. Dipeptidyl peptidase 4 inhibitor reduces intimal hyperplasia in rabbit autologous jugular vein graft under poor distal runoff. J Vasc Surg. 2016;63(5):1360–1370. doi:10.1016/j.jvs.2014.12.04825656593
   PubMedGoogle Scholar
• Kagal UA, Angadi NB, Matule SM. Effect of dipeptidyl peptidase 4 inhibitors on acute and subacute models of inflammation in male Wistar rats: an experimental study. Int J Appl Basic Med Res. 2017;7(1):26–31. doi:10.4103/2229-516X.19851628251104
   PubMedGoogle Scholar
• Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362(6423):801–809. doi:10.1038/362801a08479518
   PubMed Web of Science ®Google Scholar